Abstract
The incidence of glioblastoma, previously described as a disease predominantly affecting non‐Hispanic White patients, was higher among non‐White patients in the authors' recent study in which the racial/ethnical composition of the patients was representative of the overall population. These findings offer an opportunity to accurately redefine the patient population of patients with glioblastoma bearing the burden of this disease in the United States.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
